Clinical trials
Phase 1 Hematologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 8 |
| Terminated | 8 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 13 |
| Baylor College of Medicine | 2 |
| Celularity Incorporated | 2 |
| Novartis Pharmaceuticals | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Bioverativ, a Sanofi company | 1 |
| Celgene | 1 |
| Cellenkos, Inc. | 1 |
| Cellphire Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 48 |
| Lymphoma | 12 |
| Multiple Myeloma | 12 |
| Immunoproliferative Disorders | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoproliferative Disorders | 8 |
| Neoplasms | 7 |
| Anemia, Sickle Cell | 6 |
| Hemorrhagic Disorders | 6 |
| Neoplasms, Plasma Cell | 6 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.